Selected research
Industry Growth & Trends
Global Automated Biobanking Solution Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Automated Biobanking Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Automated Biobanking Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Automated Biobanking Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automated Biobanking Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Automated Biobanking Solution market include Thermo Fisher Scientific, Air Liquide, Brooks Automation, SPT Labtech, Modul-Bio, Azenta, LabVantage, OMNI Life Science and Calibre Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Automated Biobanking Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Automated Biobanking Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Automated Biobanking Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Automated Biobanking Solution.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Automated Biobanking Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Automated Biobanking Solution Market by Company
Thermo Fisher Scientific
Air Liquide
Brooks Automation
SPT Labtech
Modul-Bio
Azenta
LabVantage
OMNI Life Science
Calibre Scientific
IQVIA
XiltriX
Esco Lifesciences Group
Hangzhou Baocheng Biotechnology
Shanghai Origincell Biological Cryo Equipment
Anhui Zhongke Meiling Cryogenics
Shanghai H-VISIONS Technology
Qingdao Haier Biomedical
Qingdao AUCMA Biomedical
Qingdao Dashoo
Qingdao Hisense Medical
Automated Biobanking Solution Segment by Type
Sample Preparation Devices
Cryobiology Storage System
Cryobiology Storage Consumables
Environmental Monitoring System
Laboratory Information Management Systems (LIMS)
Automated Biobanking Solution Segment by Application
Universities
Hospitals
Clinical Research Laboratories
Others
Automated Biobanking Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated Biobanking Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automated Biobanking Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated Biobanking Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Automated Biobanking Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sample Preparation Devices
- Cryobiology Storage System
- Cryobiology Storage Consumables
- Environmental Monitoring System
- Laboratory Information Management Systems (LIMS)
Applications
- Universities
- Hospitals
- Clinical Research Laboratories
- Others
Companies covered
- Thermo Fisher Scientific
- Air Liquide
- Brooks Automation
- SPT Labtech
- Modul-Bio
- Azenta
- LabVantage
- OMNI Life Science
- Calibre Scientific
- IQVIA
- XiltriX
- Esco Lifesciences Group
- Hangzhou Baocheng Biotechnology
- Shanghai Origincell Biological Cryo Equipment
- Anhui Zhongke Meiling Cryogenics
- Shanghai H-VISIONS Technology
- Qingdao Haier Biomedical
- Qingdao AUCMA Biomedical
- Qingdao Dashoo
- Qingdao Hisense Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Automated Biobanking Solution Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Automated Biobanking Solution Market Size by Region (2021-2032)
- 1.4.1 Global Automated Biobanking Solution Market Size by Region (2021-2026)
- 1.4.2 Global Automated Biobanking Solution Market Size by Region (2027-2032)
- 1.5 Key Regions Automated Biobanking Solution Market Size (2021-2032)
- 1.5.1 North America Automated Biobanking Solution Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Automated Biobanking Solution Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Automated Biobanking Solution Market Size Growth Rate (2021-2032)
- 1.5.4 South America Automated Biobanking Solution Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Automated Biobanking Solution Market Size Growth Rate (2021-2032)
2 Automated Biobanking Solution Market by Type
- 2.1 Type Introduction
- 2.1.1 Sample Preparation Devices
- 2.1.2 Cryobiology Storage System
- 2.1.3 Cryobiology Storage Consumables
- 2.1.4 Environmental Monitoring System
- 2.1.5 Laboratory Information Management Systems (LIMS)
- 2.2 Global Automated Biobanking Solution Market Size by Type
- 2.2.1 Global Automated Biobanking Solution Market Size Overview by Type (2021-2032)
- 2.2.2 Global Automated Biobanking Solution Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Automated Biobanking Solution Market Size Forecasted by Type (2027-2032)
- 2.3 Global Automated Biobanking Solution Market Size by Regions
- 2.3.1 North America Automated Biobanking Solution Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Automated Biobanking Solution Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Automated Biobanking Solution Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Automated Biobanking Solution Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Automated Biobanking Solution Market Size Breakdown by Type (2021-2026)
3 Automated Biobanking Solution Market by Application
- 3.1 Type Introduction
- 3.1.1 Universities
- 3.1.2 Hospitals
- 3.1.3 Clinical Research Laboratories
- 3.1.4 Others
- 3.2 Global Automated Biobanking Solution Market Size by Application
- 3.2.1 Global Automated Biobanking Solution Market Size Overview by Application (2021-2032)
- 3.2.2 Global Automated Biobanking Solution Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Automated Biobanking Solution Market Size Forecasted by Application (2027-2032)
- 3.3 Global Automated Biobanking Solution Market Size by Regions
- 3.3.1 North America Automated Biobanking Solution Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Automated Biobanking Solution Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Automated Biobanking Solution Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Automated Biobanking Solution Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Automated Biobanking Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Automated Biobanking Solution Industry Trends
- 4.2 Automated Biobanking Solution Industry Drivers
- 4.3 Automated Biobanking Solution Industry Opportunities and Challenges
- 4.4 Automated Biobanking Solution Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Automated Biobanking Solution Revenue (2021-2026)
- 5.2 Global Automated Biobanking Solution Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Automated Biobanking Solution Key Company Headquarters & Area Served
- 5.4 Global Automated Biobanking Solution Company, Product Type & Application
- 5.5 Global Automated Biobanking Solution Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Automated Biobanking Solution Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Automated Biobanking Solution Players Market Share by Revenue in 2025
- 5.6.3 2025 Automated Biobanking Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Automated Biobanking Solution Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Air Liquide
- 6.2.1 Air Liquide Company Information
- 6.2.2 Air Liquide Business Overview
- 6.2.3 Air Liquide Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Air Liquide Automated Biobanking Solution Product Portfolio
- 6.2.5 Air Liquide Recent Developments
- 6.3 Brooks Automation
- 6.3.1 Brooks Automation Company Information
- 6.3.2 Brooks Automation Business Overview
- 6.3.3 Brooks Automation Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Brooks Automation Automated Biobanking Solution Product Portfolio
- 6.3.5 Brooks Automation Recent Developments
- 6.4 SPT Labtech
- 6.4.1 SPT Labtech Company Information
- 6.4.2 SPT Labtech Business Overview
- 6.4.3 SPT Labtech Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 SPT Labtech Automated Biobanking Solution Product Portfolio
- 6.4.5 SPT Labtech Recent Developments
- 6.5 Modul-Bio
- 6.5.1 Modul-Bio Company Information
- 6.5.2 Modul-Bio Business Overview
- 6.5.3 Modul-Bio Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Modul-Bio Automated Biobanking Solution Product Portfolio
- 6.5.5 Modul-Bio Recent Developments
- 6.6 Azenta
- 6.6.1 Azenta Company Information
- 6.6.2 Azenta Business Overview
- 6.6.3 Azenta Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Azenta Automated Biobanking Solution Product Portfolio
- 6.6.5 Azenta Recent Developments
- 6.7 LabVantage
- 6.7.1 LabVantage Company Information
- 6.7.2 LabVantage Business Overview
- 6.7.3 LabVantage Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 LabVantage Automated Biobanking Solution Product Portfolio
- 6.7.5 LabVantage Recent Developments
- 6.8 OMNI Life Science
- 6.8.1 OMNI Life Science Company Information
- 6.8.2 OMNI Life Science Business Overview
- 6.8.3 OMNI Life Science Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 OMNI Life Science Automated Biobanking Solution Product Portfolio
- 6.8.5 OMNI Life Science Recent Developments
- 6.9 Calibre Scientific
- 6.9.1 Calibre Scientific Company Information
- 6.9.2 Calibre Scientific Business Overview
- 6.9.3 Calibre Scientific Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Calibre Scientific Automated Biobanking Solution Product Portfolio
- 6.9.5 Calibre Scientific Recent Developments
- 6.10 IQVIA
- 6.10.1 IQVIA Company Information
- 6.10.2 IQVIA Business Overview
- 6.10.3 IQVIA Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 IQVIA Automated Biobanking Solution Product Portfolio
- 6.10.5 IQVIA Recent Developments
- 6.11 XiltriX
- 6.11.1 XiltriX Company Information
- 6.11.2 XiltriX Business Overview
- 6.11.3 XiltriX Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 XiltriX Automated Biobanking Solution Product Portfolio
- 6.11.5 XiltriX Recent Developments
- 6.12 Esco Lifesciences Group
- 6.12.1 Esco Lifesciences Group Company Information
- 6.12.2 Esco Lifesciences Group Business Overview
- 6.12.3 Esco Lifesciences Group Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Esco Lifesciences Group Automated Biobanking Solution Product Portfolio
- 6.12.5 Esco Lifesciences Group Recent Developments
- 6.13 Hangzhou Baocheng Biotechnology
- 6.13.1 Hangzhou Baocheng Biotechnology Company Information
- 6.13.2 Hangzhou Baocheng Biotechnology Business Overview
- 6.13.3 Hangzhou Baocheng Biotechnology Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Hangzhou Baocheng Biotechnology Automated Biobanking Solution Product Portfolio
- 6.13.5 Hangzhou Baocheng Biotechnology Recent Developments
- 6.14 Shanghai Origincell Biological Cryo Equipment
- 6.14.1 Shanghai Origincell Biological Cryo Equipment Company Information
- 6.14.2 Shanghai Origincell Biological Cryo Equipment Business Overview
- 6.14.3 Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Product Portfolio
- 6.14.5 Shanghai Origincell Biological Cryo Equipment Recent Developments
- 6.15 Anhui Zhongke Meiling Cryogenics
- 6.15.1 Anhui Zhongke Meiling Cryogenics Company Information
- 6.15.2 Anhui Zhongke Meiling Cryogenics Business Overview
- 6.15.3 Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Product Portfolio
- 6.15.5 Anhui Zhongke Meiling Cryogenics Recent Developments
- 6.16 Shanghai H-VISIONS Technology
- 6.16.1 Shanghai H-VISIONS Technology Company Information
- 6.16.2 Shanghai H-VISIONS Technology Business Overview
- 6.16.3 Shanghai H-VISIONS Technology Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Shanghai H-VISIONS Technology Automated Biobanking Solution Product Portfolio
- 6.16.5 Shanghai H-VISIONS Technology Recent Developments
- 6.17 Qingdao Haier Biomedical
- 6.17.1 Qingdao Haier Biomedical Company Information
- 6.17.2 Qingdao Haier Biomedical Business Overview
- 6.17.3 Qingdao Haier Biomedical Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Qingdao Haier Biomedical Automated Biobanking Solution Product Portfolio
- 6.17.5 Qingdao Haier Biomedical Recent Developments
- 6.18 Qingdao AUCMA Biomedical
- 6.18.1 Qingdao AUCMA Biomedical Company Information
- 6.18.2 Qingdao AUCMA Biomedical Business Overview
- 6.18.3 Qingdao AUCMA Biomedical Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Qingdao AUCMA Biomedical Automated Biobanking Solution Product Portfolio
- 6.18.5 Qingdao AUCMA Biomedical Recent Developments
- 6.19 Qingdao Dashoo
- 6.19.1 Qingdao Dashoo Company Information
- 6.19.2 Qingdao Dashoo Business Overview
- 6.19.3 Qingdao Dashoo Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Qingdao Dashoo Automated Biobanking Solution Product Portfolio
- 6.19.5 Qingdao Dashoo Recent Developments
- 6.20 Qingdao Hisense Medical
- 6.20.1 Qingdao Hisense Medical Company Information
- 6.20.2 Qingdao Hisense Medical Business Overview
- 6.20.3 Qingdao Hisense Medical Automated Biobanking Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Qingdao Hisense Medical Automated Biobanking Solution Product Portfolio
- 6.20.5 Qingdao Hisense Medical Recent Developments
7 North America
- 7.1 North America Automated Biobanking Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Automated Biobanking Solution Market Size by Country (2021-2026)
- 7.3 North America Automated Biobanking Solution Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Automated Biobanking Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Automated Biobanking Solution Market Size by Country (2021-2026)
- 8.3 Europe Automated Biobanking Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Automated Biobanking Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Automated Biobanking Solution Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Automated Biobanking Solution Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Automated Biobanking Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Automated Biobanking Solution Market Size by Country (2021-2026)
- 10.3 South America Automated Biobanking Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Automated Biobanking Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Automated Biobanking Solution Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Automated Biobanking Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst